November 21st
November 20th
November 19th
Long-term antibiotics reduce COPD exacerbations, raise questions - EurekAlert
Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study. "Our results show a ...
UA concept: Thwart pathogens' teamwork - Arizona Daily Star
Rather than attacking drug-resistant germs head-on, a UA researcher is proposing an insurgent-like approach that destroys the links that allow an infection to survive. Evolving pathogens such as methicillin-resistant Staphylococcus aureus , commonly ...
Actavis donates medicines to Smolyan Municipality - Focus Infomation
Smolyan. Actavis pharmaceutic company continues its charity campaign for donation of medicines from its rich commodity list to the Bulgarian municipalities, press centre of the company announced today. After charity campaign in the towns of Veliko ...
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad ... - Marketwatch
BASEL, SWITZERLAND, Nov 21, 2008 (MARKET WIRE via COMTEX) -- Basilea Pharmaceutica Ltd. announces that Zevtera(TM) (ceftobiprole medocaril), the first-in-class anti-MRSA broad-spectrum cephalosporin, received a positive opinion from the Committee for ...
Targanta shares dive 82% after drug is rejected - Boston Globe
Shares of Targanta Therapeutics Corp. plummeted 82 percent yesterday, a day after the Cambridge biotechnology company failed to convince a federal advisory panel that its key product, an experimental antibiotic, should be approved. The Food and Drug ...
Do you prefer to listen to your antibiotics gossip? Check out Podzy Podcast Directory > Antibiotics.
Looking for antibiotics related products, then look no further. Try our new Antibiotics Shop.